13F reference period
n/a
Security Snapshot
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) Institutional Ownership
CUSIP: M8769Q102
13F Institutional Holders and Ownership History from Q2 2025 to Q3 2026
Institutions Reporting
Shares (Excl. Options)
n/a
Price
$41.17
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.10 per share
- Symbol
- TEVA on NYSE
- Shares outstanding
- 1,173,636,683
- SEC-reported price per share
- $41.17
- Insider filing price
- $41.17
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share is tracked under CUSIP M8769Q102.
- 13F reference-period holder data is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
M8769Q102
13F reference period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
TEVA full holder history
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
TEVA PHARMACEUTICAL INDUSTRIES LTD insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP M8769Q102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
TEVA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Harel Insurance Investments & Financial Services Ltd. | 6% | -5% | $2,899,117,335 | -$78,525,764 | 70,418,201 | -2.6% | Harel Insurance Investments & Financial Services Ltd. | 30 Sep 2026 |
| FMR LLC | 2.1% | -60% | -$561,363,714 | 24,641,361 | -58% | FMR LLC | 30 Sep 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
n/a
Rows shown
1-4 of 4